Incannex Healthcare Inc. (IXHL) stock: key figures, P/E, revenue and dividend
Health Care · ISIN US45333F2083
Incannex Healthcare Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 86,000.00 USD | 0.00 USD |
| Operating income | -23.79 m USD | -23.03 m USD |
| EBIT | -46.64 m USD | – |
| Net income | -46.89 m USD | -19.30 m USD |
| Diluted EPS – continuing operations | -1.35 USD | -1.66 USD |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Incannex Healthcare Inc.
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
More stocks
- ConnectM Technology Solutions, Inc. (CNTM)
- OLD MARKET CAPITAL Corp (OMCC)
- HeartBeam, Inc. (BEAT)
- PIONEER POWER SOLUTIONS, INC. (PPSI)
- TABLE TRAC INC (TBTC)
- Retrieve Medical Holdings, Inc. (RMHI)
- TOMI Environmental Solutions, Inc. (TOMZ)
- FAMILY OFFICE OF AMERICA, INC. (FOFA)
- NewHydrogen, Inc. (NEWH)
- ABVC BIOPHARMA, INC. (ABVC)
- SYPRIS SOLUTIONS INC (SYPR)
- BeyondSpring Inc. (BYSI)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.